R-BAC Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of rituximab, bendamustine and cytarabine that can be used in the treatment of mantle cell lymphoma (MCL). RBAC500 regimen, consisting of bendamustine, low-dose cytarabine and rituximab, may be used for the treatment of MCL.

**Synonyms:** - Bendamustine/Cytarabine/Rituximab - R-BAC - R-BAC - R-BAC (rituximab-abbs) - R-BAC (rituximab-arrx) - R-BAC (rituximab-blit) - R-BAC (rituximab-pvvr) - R-BAC (rituximab-rite) - R-BAC (rituximab-rixa) - R-BAC (rituximab-rixi) - RBAC Regimen - Rituximab-Bendamustine-Cytarabine - Rituximab/Bendamustine/Ara-C